3Tsang T S, Enriquez-Sarano M, Freeman W K. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21years [J]. Mayo Clin Proc, 2002,77(5): 429.
3Tomkowski WZ, Wisniewska J, Szturmowicz M, et al. Evaluation of intrapericardial eisplatin administration in eases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer, 2004, 12:53-57.
4Lestuzzi C, Lafaras C, Bearz A, et al. Malignant pericardial effusion: sclerotherapy or local chemotherapy? British Journal of Cancer, 2009, 101:734-735.
6D' Addario G, Felip E. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 2008, 19 :ii39-ii40.
7张进华,曹利娟,任迎春.肺癌[M].北京:军事医学科学出版社,2007:394-395.
8Oha K, Kobayashi M, Matsui T, et al. Individual patient based recta- analysis of Lentinan for unresectabie/reeurrent gastric cancer [ J ]. Anticancer Res,2009, 29 ( 7 ) :2739 - 2745.
9Kataoka I-I, Shimura T, Mizoshita T, et al. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life[ J]. ttepatogastroenterology , 2009,6(90) :47 -50.
